Generate Life Sciences Supports Rutgers Cancer Institute's Cord Blood Research With Critical Bioprocessing Device Donation

/PRNewswire/ -- Generate Life Sciences today announced it is donating a Sepax 2 S-100 cell bioprocessing system manufactured by Cytiva to Rutgers Cancer...

Related Keywords

Australia ,United States ,Canada ,San Francisco ,California ,Los Angeles ,Insception Lifebank ,Azeem Zeekrya ,Cytiva Sepax ,Archana Sharma ,Jaime Shamonki ,Pediatric Hematologist Oncologist At Rutgers Cancer Institute ,Robert Wood Johnson University Hospital ,Family Health Registry ,Newborn Possibilities Program ,Cord Blood Advantage Program ,Life Sciences ,Donor Egg Bank United States ,Generate Life Sciences ,Rutgers Cancer Institute ,New Jersey ,Chief Medical ,Blood Advantage Program ,Health Registry ,Possibilities Program ,Cord Blood Registry ,Cell Care ,California Cryobank ,Kitazato United States ,Donor Application ,